120 related articles for article (PubMed ID: 9616975)
1. [Humoral and cellular immunity in response to BCG vaccination. A study of a sample of students of the Campania region].
Liguori G; Maselli R; Di Benedetto R; de Angelis CP; Marinelli A; Marinelli P
Ann Ig; 1998; 10(1):25-34. PubMed ID: 9616975
[No Abstract] [Full Text] [Related]
2. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
3. [BCG vaccination of medical students of the University of Naples: findings concerning the evolution of the vaccination site and the BCG allergy].
Galzerano G; Dericoloso A; Goatley ML; Mazzarella G
Arch Monaldi; 1980; 35(3):143-7. PubMed ID: 7316664
[No Abstract] [Full Text] [Related]
4. The humoral immune response after BCG vaccination: an immunoblotting study using two purified antigens.
Drowart A; Selleslaghs J; Yernault JC; Valcke C; De Bruyn J; Huygen K; Farber CM; Van Vooren JP
Tuber Lung Dis; 1992 Jun; 73(3):137-40. PubMed ID: 1421345
[TBL] [Abstract][Full Text] [Related]
5. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
6. The cytokine response to bacille Calmette Guérin vaccination in South India.
Das SD; Narayanan PR; Kolappan C; Colston MJ
Int J Tuberc Lung Dis; 1998 Oct; 2(10):836-43. PubMed ID: 9783532
[TBL] [Abstract][Full Text] [Related]
7. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.
Mori T; Sakatani M; Yamagishi F; Takashima T; Kawabe Y; Nagao K; Shigeto E; Harada N; Mitarai S; Okada M; Suzuki K; Inoue Y; Tsuyuguchi K; Sasaki Y; Mazurek GH; Tsuyuguchi I
Am J Respir Crit Care Med; 2004 Jul; 170(1):59-64. PubMed ID: 15059788
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the level of antibodies (IgG) to BCG in blood before and after BCG vaccination].
Gao DZ
Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(3):168-70, 192. PubMed ID: 3449235
[No Abstract] [Full Text] [Related]
9. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
10. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations.
Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM
Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073
[TBL] [Abstract][Full Text] [Related]
11. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
12. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
Griffin JF; Mackintosh CG; Rodgers CR
Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638
[TBL] [Abstract][Full Text] [Related]
14. BCG and prospects for new vaccines against tuberculosis.
Ortona L; De Luca A
Rays; 1998; 23(1):225-30. PubMed ID: 9673148
[TBL] [Abstract][Full Text] [Related]
15. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against tuberculosis.
Ebrahim GJ
J Trop Pediatr; 2006 Oct; 52(5):305-6. PubMed ID: 17008443
[No Abstract] [Full Text] [Related]
18. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
[TBL] [Abstract][Full Text] [Related]
19. [The immunity conferred by BCG vaccination in relation to the degree of induced tuberculin sensitivity].
Hart D; Sutherland I
Tuberkuloza; 1966; 18(1-3):38-40. PubMed ID: 16296065
[No Abstract] [Full Text] [Related]
20. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
Giri PK; Verma I; Khuller GK
J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
